BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Transinsight GmbH Release: Genecloud - Semantic High Performance Cloud Computing Software for the Life Sciences


3/7/2011 10:41:04 AM

Hannover, Germany, March 01st: - Today, the German Federal Ministry of Economics and Technology (BMWi) announced the 12 winners of the Trusted Cloud research program at the 2011 CeBIT in Hannover. Trusted Cloud fosters the development of secure cloud computing services. A total of 116 proposals were submitted to the 100 Mio Euro program.

GeneCloud, a proposal developed by Transinsight, TU Dresden, Antibodies Online, RESprotect, and Qualitype was selected as one of the 12 winners. The goal of GeneCloud is the development of cloud computing services for the life sciences.

Today, the main problem for small and medium sized enterprises in the pharmaceutical industry is the access to high performance computing to analyze high-throughput experiments. In drug development, prediction of biomarkers, drug-target interactions and side effects are computationally intensive problems that will benefit from cloud computing. "In order to better understand and treat diseases such as cancer, data analysis and computing plays an increasing role. Small companies should be enabled to use today’s computing power available in the cloud. However, the key problem is data security. Up to now there is a great barrier to release relevant data into the cloud. This problem is addressed in GeneCloud: we develop secure high-performance cloud computing services for the Life Science", says Dr. Michael R. Alvers, CEO of Transinsight.

Prof. Dr. Michael Schroeder of TU Dresden states: "The understanding of protein- and gene-networks is of high relevance to develop medicine faster, cheaper and with less side effects. In GeneCloud we will adopt our state-of-the-art award-winning algorithms to the needs of small players. By a combination of cryptography and stenography we will secure critical data, that no one else but the owner can get insights provided by the cloud computers".

On top of winning the Trusted Cloud competition, Transinsight was awarded with the German Innovation Prize IT for its outstanding developments in Enterprise Semantic Intelligence at CeBIT 2011. The prize was given to 43 companies and research groups out of over 2000 submissions.

About Transinsight GmbH

Transinsight develops knowledge-based solutions. Their semantic software platform Enterprise Semantic Intelligence™ powers the knowledge-based search systems www.Go3R.org, www.GoPubMed.com and www.find42.com, semantic search engines, of the next generation. In acknowledgement of the technologies developed by the company, Transinsight has repeatedly been honored with international awards amongst others the reddot design award communication design - best of the best 2009, the German Industry Prize 2010 and the German Innovation Prize IT in 2011. The firm works in close collaboration with the Dresden University of Technology. Selected customers are: Unilever, BASF, BfR, Statoil, RWE, Abcam und EMBL. Internet: http://www.transinsight.com/news11



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES